• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There are few data regarding how exposure over time may affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the benefits of using them against the risks to the foetus. Physicians don't have the information needed to provide clear recommendations however they can provide information about the risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who were taking adhd medication for adults uk medications during early pregnancy did not face an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a large sample-based case control study to examine the prevalence of structural defects that were major in infants who were born to mothers who used stimulants during pregnancy. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure correct case classification and to limit the chance of bias.

However, the study had its limitations. In particular, they were unable to separate the effects of the medication from the disorder that is underlying. This makes it difficult to know whether the limited associations observed in the exposed groups result from medication use or confounding by comorbidities. In addition the researchers did not study the long-term outcomes of offspring.

The study did reveal that infants whose mothers had taken ADHD medications during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or taken off their medication prior to or during pregnancy. This increase was due to central nervous system disorders, and the increased risk of admission did not appear to be influenced by which stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having to have a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

Researchers suggest that the minor risks associated with the use ADHD medications in early pregnancies may be offset by the greater benefits to both mother and baby from continuing treatment for the woman's condition. Doctors should discuss with their patients about this and, if possible, help them develop coping strategies that could reduce the impact of her disorder in her daily life and relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. Often, these decisions are made without clear and authoritative evidence in either case, which means that doctors have to weigh their experience, the experiences of other doctors, and what the research suggests on the subject as well as their best judgment for each patient.

Particularly, the subject of potential risks to the baby can be a challenge. Many of the studies on this topic are based on observational evidence rather than controlled research and their findings are often contradictory. most common adhd medications studies limit their analysis to live births, which can underestimate the teratogenic impact which can you get adhd medication without a diagnosis cause terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these limitations, by examining both information on deceased and live births.

The conclusion is that while some studies have found that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no connection and the majority of studies show a neutral or even slightly negative impact. In every case it is imperative to conduct a thorough evaluation of the benefits and risks should be conducted.

It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of isolation. Additionally, the loss of medication can affect the ability to complete jobs and drive safely that are crucial aspects of daily life for many people with ADHD.

She suggests that women who aren't sure whether to continue taking the medication or discontinue it due to pregnancy should educate family members, coworkers and acquaintances about the condition, the impact on daily functioning and the benefits of keeping the current treatment. It can also help women feel more confident in her decision. Certain medications can pass through the placenta. If a patient decides to stop taking her liquid adhd medication medication while breastfeeding, it is important to be aware that the medication could be passed on to her infant.

Risk of Birth Defects

As the use and use of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as does the concern about the possible effects of the drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this issue. Utilizing two huge data sets researchers were able to examine more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the overall risk is low, first-trimester ADHD medication exposure was associated with slightly higher risk of specific heart defects like ventriculoseptal defect.

The researchers of the study did not find any association between early use of medication and other congenital anomalies such as facial deformities or club feet. The results are in the same vein as previous studies which showed the existence of a slight, but significant increase in the number of cardiac malformations among women who began taking ADHD medication before pregnancy. The risk increased in the latter stages of pregnancy when a large number of women stopped taking their medication.

Women who took ADHD medication during the first trimester were more likely require a caesarean delivery, have an insufficient Apgar after birth and have a baby who needed breathing assistance at birth. However the authors of the study were unable to eliminate selection bias by limiting the study to women who didn't have other medical issues that could have contributed to these findings.

The researchers hope their study will serve to inform the clinical decisions types of adhd medication (https://disciplined-taro-Mp67Ww.mystrikingly.com/blog/the-most-valuable-advice-you-can-ever-get-about-Non-prescription-adhd) physicians who see pregnant women. They advise that while a discussion of the benefits and risks is important, the decision to stop or continue treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also warn that while discontinuing the medications is an option, it is not a recommended practice because of the high incidence of depression and other mental health issues in women who are pregnant or who are recently postpartum. Additionally, the research suggests that women who choose to stop taking their medications are more likely to have difficulties getting used to life without them following the baby's arrival.

Nursing

The responsibilities of a new mother can be overwhelming. Women with ADHD who have to manage their symptoms while attending physician appointments, getting ready for the arrival of a child and getting used to new routines at home are often faced with a number of difficulties. This is why many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant medications are absorbed through breast milk in low amounts, so the risk to infant who is breastfeeding is low. However, the frequency of medication exposure to the newborn may differ based on the dosage, frequency it is administered and the time of the day the medication is administered. In addition, individual medications enter the baby's system differently through the gastrointestinal tract and breast milk, and the effect of this on a newborn infant is not yet fully known.

Due to the absence of research, some physicians may be inclined to discontinue stimulant drugs during a woman's pregnancy. This is a difficult decision for the mother, who must weigh the advantages of her medication against the risks to the embryo. As long as there is no more information, GPs should ask all pregnant patients about their experience with ADHD and whether they are taking or planning to take medication during the perinatal period.

A growing number of studies have proven that women can continue taking their ADHD medication during pregnancy and while breastfeeding. As a result, more and more patients are choosing to do so, and after consulting with their doctor, they have discovered that the benefits of maintaining their current medication exceed any risk.

Women with ADHD who are planning to breastfeed should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also learn about treatment options and strengthen the coping mechanisms. This should be a multidisciplinary approach including obstetricians, GPs and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, monitoring of signs of deterioration and, if needed modifications to the medication regime.